Barclays PLC Purchases 16,233 Shares of Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE)
Barclays PLC grew its position in Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE – Free Report) by 29.8% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 70,741 shares of the company’s stock after buying an additional 16,233 shares during the period. Barclays PLC’s holdings in Monte Rosa […]
Barclays PLC grew its position in Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE – Free Report) by 29.8% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 70,741 shares of the company’s stock after buying an additional 16,233 shares during the period. Barclays PLC’s holdings in Monte Rosa […]
